Octreotide Injection, Solution
Product Images NDC 63323-378

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Octreotide (NDC 63323-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oct03 0002 01

Chemical structure diagram showing the molecular formula of octreotide acetate, identifying amino acid residues in the peptide chain and the variable components represented by 'x' and 'z' with specified ranges.*

FDA Label Image

Oct03 0002 02

FDA Label Image

Oct03 0002 03

Label for Octreotide Acetate Injection, 100 mcg per mL, in a 1 mL single dose vial. The injection is preservative free and intended for subcutaneous or intravenous use. Labeler is Fresenius Kabi USA, LLC. Includes barcode and lot/expiration area.*

FDA Label Image

Oct03 0002 04

Label for Octreotide Acetate Injection 100 mcg per mL by Fresenius Kabi USA, LLC. The label indicates the product is preservative free, for subcutaneous or intravenous use, supplied as 10 single-dose vials of 1 mL each. Storage instructions and ingredients are also listed on the label.*

FDA Label Image

Oct03 0002 05

Label for Octreotide Acetate Injection 500 mcg per mL in a 1 mL single dose vial. The label indicates intravenous or subcutaneous use, notes it is preservative free, and includes instructions to protect from light and discard unused portion. The labeler is Fresenius Kabi.*

FDA Label Image

Oct03 0002 06

Octreotide Acetate Injection, 500 mcg per mL, preservative free, for subcutaneous or intravenous use. The label indicates a single-dose vial of 10 x 1 mL, manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. It includes storage instructions and a list of inactive ingredients.*

FDA Label Image

Oct03 0002 07

Label for Octreotide Acetate Injection, 1000 mcg per 5 mL (200 mcg per mL) strength in a 5 mL multiple dose vial. Intended for subcutaneous or intravenous use. The label includes storage instructions to refrigerate at 2°C to 8°C and discard within 14 days after initial use. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Oct03 0002 08

Label for Octreotide Acetate Injection 1000 mcg per 5 mL (200 mcg per mL) by Fresenius Kabi USA, LLC. The label includes information on composition, storage instructions to refrigerate at 2° to 8°C and protect from light, usage for subcutaneous or intravenous injection, and packaging as a 5 mL multiple dose vial. The label also features a barcode and the Fresenius Kabi logo.*

FDA Label Image

Oct03 0002 09

Octreotide Acetate Injection label for 5,000 mcg per 5 mL (1,000 mcg per mL) in a 5 mL multiple dose vial. The label indicates use for subcutaneous or intravenous administration. It is sterile and Rx only, labeled by Fresenius Kabi USA, LLC, with storage instructions to refrigerate and protect from light.*

FDA Label Image

Oct03 0002 10

Label for Octreotide Acetate Injection, 5,000 mcg per 5 mL (1,000 mcg per mL) by Fresenius Kabi USA, LLC. The label specifies the product as a sterile injection solution for subcutaneous or intravenous use, multiple dose vial 5 mL, with storage instructions to refrigerate at 2°C to 8°C and discard within 14 days after initial use. The label includes ingredient details and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.